Why the study?
What is the role of various antithrombotic therapies in preventing stroke in patients with nonvalvular atrial fibrillation?
What is the role of various antithrombotic therapies in preventing stroke in patients with nonvalvular atrial fibrillation?
This narrative review summarizes the evolution and efficacy of antithrombotic therapies, including VKAs and DOACs, for stroke prevention in nonvalvular atrial fibrillation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Sá et al. (2011) conducted a review in Atrial fibrillation. Antithrombotic therapy was evaluated.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: